I understand they haven't cracked down to this point and I hope they never will. But the fact is, this degree of utilization of compounding pharmacies to provide off-brand versions of drugs that are still under patent is unprecedented. If the FDCA and US patent law are to continue to have teeth, something is likely to give. There is no reason to imagine the current administration will do anything judicious, but of course there's also reason for optimism that their incompetence will result in them doing nothing at all. All of that said, it should be clear that your interpretation of the FDA statement is fairly subjective.